CMS Reconfigures Cardiac DRGs To Reflect Case Severity – IPPS Final Rule

Cardiac manufacturers are evaluating how payments for drug-eluting stents, pacemakers and coronary artery bypass grafts (CABG) will be affected by CMS' decision to reconfigure nine cardiovascular DRGs